The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy

Paweł Gajdanowicz; Dries van Elst; Sylwia Smolińska; Andrzej Eljaszewicz; Liam O'Mahony; Alexander Kettner; Marek Jutel

doi:10.1111/all.14342

The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy

Paweł Gajdanowicz
, Dries van Elst
, Sylwia Smolińska
, Andrzej Eljaszewicz
, Liam O'Mahony
, Alexander Kettner
, Marek Jutel^*

^*Corresponding author for this work

Wrocław Medical University
ALL-MED Medical Research Institute, Breslau, Polen
Medical University of Białystok
Universität Zürich
University College Cork
Anergis SA

Research output: Contribution to journal › Comment/Letter to the editor › Academic

10 Downloads (Pure)

Original language	English
Pages (from-to)	2685-2686
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	75
Issue number	10
DOIs	https://doi.org/10.1111/all.14342
Publication status	Published - 1 Oct 2020
Externally published	Yes

Access to Document

10.1111/all.14342

The-frequency-of-cd4--cd25--foxp3--cd127--cells-in-bet-v-1-contiguous-overlapping-peptide-immunotherapy-as-a-putativ.pdfFinal published version, 391 KB

Cite this

@article{cb6b0159197148c18d55e91bb0b2d106,

title = "The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy",

author = "Pawe{\l} Gajdanowicz and \{van Elst\}, Dries and Sylwia Smoli{\'n}ska and Andrzej Eljaszewicz and Liam O'Mahony and Alexander Kettner and Marek Jutel",

year = "2020",

month = oct,

day = "1",

doi = "10.1111/all.14342",

language = "English",

volume = "75",

pages = "2685--2686",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley Blackwell",

number = "10",

}

Gajdanowicz, P, van Elst, D, Smolińska, S, Eljaszewicz, A, O'Mahony, L, Kettner, A & Jutel, M 2020, 'The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy', Allergy: European Journal of Allergy and Clinical Immunology, vol. 75, no. 10, pp. 2685-2686. https://doi.org/10.1111/all.14342

The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy. / Gajdanowicz, Paweł; van Elst, Dries; Smolińska, Sylwia et al.
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, No. 10, 01.10.2020, p. 2685-2686.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy

AU - Gajdanowicz, Paweł

AU - van Elst, Dries

AU - Smolińska, Sylwia

AU - Eljaszewicz, Andrzej

AU - O'Mahony, Liam

AU - Kettner, Alexander

AU - Jutel, Marek

PY - 2020/10/1

Y1 - 2020/10/1

UR - https://www.scopus.com/pages/publications/85084567479

UR - https://www.ncbi.nlm.nih.gov/pubmed/32339292

U2 - 10.1111/all.14342

DO - 10.1111/all.14342

M3 - Comment/Letter to the editor

C2 - 32339292

SN - 0105-4538

VL - 75

SP - 2685

EP - 2686

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 10

ER -

The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy

Access to Document

Other files and links

Cite this